A lethal new strain of bird flu, called H10N8, has been identified in China. The virus killed a 73-year-old woman in the city of Nanchang in Jiangxi province last December, Financial Times reported, citing a case report in the Lancet on Wednesday. Mingbin Liu from Nanchang City Centre for Disease Control and Prevention told the […]
Category: Health Care
2013 in review
Glaxo’s China sales plunge 61%
UK drugmaker GlaxoSmithKline (GSK.NYSE, GSK.LON) said third-quarter sales fell by 61% in China due to an anti-corruption probe that started in July, Bloomberg reported, citing a company statement on Wednesday. The company has been accused of bribing hospitals, doctors and officials. Revenue from consumer health-care products in China fell 29% and the drugmaker gave no outlook […]
The Chengdu Institute of Biological Products has gained World Health Organization regulatory approval for its Japanese encephalitis vaccine, Financial Times reported. This is the first time a Chinese vaccine company has been given the green light by an international organization. WHO approval of the Chengdu Institute’s vaccine allows it to market products more widely rather than seeking […]
GlaxoSmithKline (GSK.NYSE, GSK.LON) sales are thought to have fallen up to 30% as Chinese officials accuse the UK pharmaceutical group of corruption, Financial Times reported, citing Citi Bank research. Analysts have predicted a slowdown in the industry as China continues corruption and pricing probes into western and domestic drug companies. Andrew Baum, an analyst with […]